Cardiovascular disease and CKD: core curriculum 2010.
Shastri
Shani
S
Tufts University School of Medicine, Boston, MA, USA.
Sarnak
Mark J
MJ
D054058:Acute Coronary Syndrome / Q000453:epidemiology; D000740:Anemia / Q000453:epidemiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000628:therapy; D006328:Cardiac Catheterization; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000401:mortality; D008078:Cholesterol, LDL / Q000097:blood; D015897:Comorbidity; D003928:Diabetic Nephropathies / Q000453:epidemiology / Q000503:physiopathology; D050171:Dyslipidemias / Q000453:epidemiology; D004562:Electrocardiography; D006333:Heart Failure / Q000453:epidemiology; D006349:Heart Valve Diseases / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology; D006710:Homocysteine / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D006973:Hypertension / Q000453:epidemiology; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology; D008019:Life Style; D017202:Myocardial Ischemia / Q000453:epidemiology; D018384:Oxidative Stress / Q000502:physiology; D010493:Pericarditis / Q000175:diagnosis / Q000209:etiology; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology; D020107:Troponin T / Q000097:blood
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D020107:Troponin T; D006710:Homocysteine